Target intelligence / Profile preview

2'-5'-Oligoadenylate synthetase 1 (OAS1)

Target
OAS1
Molecular classification
Enzyme, Interferon-stimulated gene (ISG) product, Pattern recognition receptor (PRR) (for viral dsRNA)[2]
01

Overview

2'-5'-Oligoadenylate synthetase 1 (OAS1) is an interferon-induced enzyme that plays a key role in innate antiviral immunity. Upon binding viral double-stranded RNA, OAS1 catalyzes the synthesis of 2'-5'-linked oligoadenylates from ATP, which activate RNase L to cleave single-stranded RNA, thereby inhibiting viral replication and inducing apoptosis. OAS1 activity is determined by both sequence and structural features of the RNA ligand, and its function may be modulated by isoform diversity, genetic variation, and interaction with cellular proteins. Dysregulation of OAS1 is implicated in susceptibility to viral infections and may contribute to immune pathology under certain conditions[1][2][3].

Other names
2'-5'-oligoadenylate synthase 1OIAS(2-5')oligo(A) synthase 12-5A synthase 1OIASIIFI-4E18/E16p46/p42 OAS2'-5'-oligoadenylate synthase 1 isoform p4240/46kDa2'-5'-oligoisoadenylate synthetase 12-5A synthetase 1E16 (2'-5') oligo A synthetase[3]
02

Mechanism of action

Double-stranded RNA (dsRNA) binding leads to enzyme activation[2] Synthesizes 2'-5'-linked oligoadenylates (2-5A) from ATP 2-5A activates latent RNase L, resulting in RNA cleavage and inhibition of viral replication[2]

03

Biological functions

Innate immune responseViral dsRNA sensingActivation of RNase LRNA degradation/antiviral activity[2][3]
04

Disease associations

Infection (especially viral infection)Immune response dysregulationPotential roles in inflammation and autoimmune disorders
05

Safety considerations

Overactivation may contribute to unwanted degradation of cellular RNA and trigger autoimmune or inflammatory responses[2]Insufficient activation increases susceptibility to viral infection[2]
06

Interacting drugs

Currently, there are no approved drugs that directly target OAS1

2 more in the full profile.

07

Biomarkers

OAS1 mRNA or protein expression as a biomarker for interferon response or viral infection (e.g., in COVID-19)[3]OAS1 genetic polymorphisms/isoforms as prognostic or susceptibility markers in viral infections and immune-mediated diseases[3]

Beyond the preview

Go deeper on 2'-5'-Oligoadenylate synthetase 1 (OAS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2'-5'-Oligoadenylate synthetase 1 (OAS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call